132 related articles for article (PubMed ID: 34355418)
1. Oesophageal post-therapy myeloid sarcoma masquerading as poorly differentiated adenocarcinoma: a diagnostic pitfall.
Karamchandani DM; Go P; Bayerl M; Karamchandani K
Histopathology; 2022 Feb; 80(3):604-606. PubMed ID: 34355418
[No Abstract] [Full Text] [Related]
2. Therapy-related myeloid sarcoma with an NPM1 mutation.
Bhatta S; Kut V; Petronic-Rosic V; Hyjek E; Larson RA
Leuk Lymphoma; 2010 Nov; 51(11):2130-1. PubMed ID: 20858094
[No Abstract] [Full Text] [Related]
3. A case of acute promyelocytic leukemia presenting with a nonleukemic granulocytic sarcoma of the ovary, with subsequent development of acute myeloid leukemia associated with t(8;21).
Wang X; Liu H; Wu Z; Xu X; Chen X; Zhai Z; Sun Z
Leuk Res; 2009 Apr; 33(4):580-2. PubMed ID: 18804280
[No Abstract] [Full Text] [Related]
4. Therapy-related acute myeloid leukemia secondary to histiocytic sarcoma.
Wu W; Jing Y; Xu Q; Hao J
Minerva Med; 2021 Oct; 112(5):655-657. PubMed ID: 31958922
[No Abstract] [Full Text] [Related]
5. Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer.
Damodaran S; Bellavia T; Sait SN; Wang ES; Wetzler M; Khushalani NI
Clin Colorectal Cancer; 2012 Jun; 11(2):151-4. PubMed ID: 22133502
[No Abstract] [Full Text] [Related]
6. Mitoxantrone-related acute myelocytic leukemias.
Hossfeld DK
Ann Oncol; 2000 Oct; 11(10):1215-6. PubMed ID: 11106108
[No Abstract] [Full Text] [Related]
7. Secondary acute myelogenous leukemia following treatment with oral etoposide.
Katato K; Flaherty L; Varterasian M
Am J Hematol; 1996 Sep; 53(1):54-5. PubMed ID: 8813107
[No Abstract] [Full Text] [Related]
8. Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
Niparuck P; Kanoksil W; Chuncharunee S; Boonsakan P; Ungkanont A; Angchaisuksiri P; Karntisaviwat K; Apilugsanachit A; Rerkamnuatchoke B; Jootar S; Nitiyanant P; Atichartakarn V
Leuk Lymphoma; 2010 Nov; 51(11):2120-5. PubMed ID: 20846095
[No Abstract] [Full Text] [Related]
9. Oligometastatic recurrence of an oesophageal adenocarcinoma at a chest drain site following radical treatment: palliative treatment or resection?
Wen D; Collantes E; Sgromo B
Clin J Gastroenterol; 2018 Dec; 11(6):470-475. PubMed ID: 30145768
[TBL] [Abstract][Full Text] [Related]
10. Tracking chemotherapy's effects on secondary cancers.
Brower V
J Natl Cancer Inst; 2013 Oct; 105(19):1421-2. PubMed ID: 24052617
[No Abstract] [Full Text] [Related]
11. Therapy-related acute myelogenous leukemia and myelodysplastic syndrome.
Borthakur G; Estey AE
Curr Oncol Rep; 2007 Sep; 9(5):373-7. PubMed ID: 17706165
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
Au WY; Chan LC; Liang R; Kwong YL
Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
[No Abstract] [Full Text] [Related]
13. [Therapy-related acute myeloid leukemia: role of DNA repair].
Guièze R; Ravinet A; Hermet E; Maliki Y; de Botton S; Bay JO
Bull Cancer; 2011 Mar; 98(3):247-55. PubMed ID: 21427028
[TBL] [Abstract][Full Text] [Related]
14. Brain metastasis from oesophageal adenocarcinoma.
Nwankwo N; Mirrakhimov AE; Wind KP; Bucher N
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23606394
[No Abstract] [Full Text] [Related]
15. Secondary acute myeloid leukemia arising early after cyclophosphamide treatment.
Koklu H; Tufan A; Erkul Y; Akyurek N; Civelek R
Int J Clin Pharm; 2015 Apr; 37(2):289-91. PubMed ID: 25612567
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
Fuchs HF; Hölscher AH
Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
[TBL] [Abstract][Full Text] [Related]
17. Primary oesophageal carcinoma in teens.
Kumar A; Shukla NK; Mishra MC; Shahi UP; Kapur BM
J Surg Oncol; 1992 Aug; 50(4):254-7. PubMed ID: 1640711
[TBL] [Abstract][Full Text] [Related]
18. The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinoma.
van der Kaaij RT; Snaebjornsson P; Voncken FE; van Dieren JM; Jansen EP; Sikorska K; Cats A; van Sandick JW
Eur J Cancer; 2017 May; 76():27-35. PubMed ID: 28262585
[TBL] [Abstract][Full Text] [Related]
19. Case records of the Massachusetts General Hospital. Case 19-2009. A 63-year-old woman with carcinoma of the gastroesophageal junction.
Kwak EL; Hong TS; Berger DL; Forcione DG; Uppot RN; Lauwers GY
N Engl J Med; 2009 Jun; 360(25):2656-64. PubMed ID: 19535805
[No Abstract] [Full Text] [Related]
20. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2.
Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
Oncology (Williston Park); 2005 Jun; 19(7):830, 835-6, 838 passim. PubMed ID: 16053033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
